Skip to content

Study on the Therapeutic Effect of Transcranial Magnetic Stimulation combined with Abdominal Bagua Massage in preventing post-stroke pneumonia

Study on the Therapeutic Effect of Transcranial Magnetic Stimulation combined with Abdominal Bagua Massage in preventing post-stroke pneumonia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001025
Enrollment
Unknown
Registered
2025-05-24
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Control group:Basic treatment methods plus transcranial magnetic stimulation therapy
Observation group:Basic treatment methods combined with transcranial magnetic stimulation and abdominal bagua massage therapy

Sponsors

Jinhua Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: Those meeting all of the following conditions are included cases: (1) Meet the diagnostic criteria for the acute stage of stroke; (2) Meet the diagnostic criteria for stroke; (3) Initial onset, aged 35 to 75 years old, within 72 hours of onset; (4) NIHSS score =6 points and =22 points (see Appendix 1); (5) Voluntary participation: The patient themselves or their authorized representative sign the informed consent form on their behalf. (6) Those who have the ability to comply throughout the entire research process;

Exclusion criteria

Exclusion criteria: Cases are excluded in any of the following circumstances: (1) There are serious primary diseases such as heart, liver, kidney and hematopoietic system diseases, as well as immune deficiency diseases. (2) Digestive tract disorders, such as hemorrhoids, anal fistula, anal sphincter relaxation, rectal cancer, intestinal necrosis or perforation, etc. (3) Patients who had pulmonary infection or had been using anti-infective drugs before the onset of stroke; (4) Patients with a history of pulmonary tuberculosis, lung tumors, non-infectious interstitial lung diseases, pulmonary edema and other lung diseases; (5) Patients who are receiving radiotherapy or chemotherapy, or are currently undergoing treatment with immunosuppressant drugs; (6) Pregnant and lactating women, and those with allergic constitutions.

Design outcomes

Primary

MeasureTime frame
Inflammatory indicators on lung CT;

Secondary

MeasureTime frame
NIHSS score;Counts of routine white blood cells and C-reactive protein in peripheral blood;Clinical symptoms and signs;

Countries

China

Contacts

Public ContactHu Rongwei

Jinhua Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University

1034387300@qq.com18257026075

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026